We represented existing investor Humana, Inc. in its investment in Monogram Health, a benefit management and care delivery company for individuals with chronic kidney and end of stage renal disease. The $160 million Series B funding round led by TPG Capital will be used by Monogram to further solidify its role as the preeminent leader in personalized, compassionate, and evidence-based kidney care for patients.